TABLE 2

Serum chemokine levels in control subjects and in individuals with IGT or type 2 diabetes

Control subjectsIGTType 2 diabetes
IL-8 (pg/ml)13.48 (10.03–16.96) (244)13.52 (9.63–16.96) (239)16.59* (13.12–22.08) (230)
RANTES (ng/ml)19.93 (14.22–29.28) (242)25.96* (18.05–38.33) (239)28.29* (17.95–44.50) (230)
IP-10 (pg/ml)281.0 (193.8–438.4) (243)310.2 (214.7–445.8) (238)291.8 (186.7–426.5) (227)
Eotaxin (pg/ml)74.4 (40.6–106.8) (241)74.3 (41.5–109.6) (239)76.6 (48.2–113.3) (229)
  • Data are medians (interquartile range) (n) and are compared with control subjects using the Wilcoxon’s test.

  • *

    * P < 0.001 compared with normoglycemic control subjects.